Biodesix, Inc. Common Stock

BDSXNASDAQUSD
15.46 USD
1.04 (6.30%)AT CLOSE (11:59 AM EDT)
15.64
0.18 (1.16%)
POST MARKET (AS OF 06:56 PM EDT)
Post Market
AS OF 06:56 PM EDT
15.64
0.18 (1.16%)
🔴Market: CLOSED
Open?$16.28
High?$16.28
Low?$15.21
Prev. Close?$16.50
Volume?33.9K
Avg. Volume?67.0K
VWAP?$15.70
Rel. Volume?0.51x
Bid / Ask
Bid?$14.50 × 600
Ask?$17.50 × 200
Spread?$3.00
Midpoint?$16.00
Valuation & Ratios
Market Cap?160.1M
Shares Out?10.4M
Float?4.9M
Float %?49.2%
P/E Ratio?N/A
P/B Ratio?17.53
EPS?-$3.09
Dividend?0.00%
Ex-Dividend?N/A

BDSX is currently priced at $15.46. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place BDSX at a fair price relative to peers.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
Employees
334
Market Cap
160.1M
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2020-10-28
Address
919 WEST DILLON ROAD
LOUISVILLE, CO 80027
Phone: 303-417-0500
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+3/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
94
Short Sent.?
95
Piotroski F-Score?4/9Mixed
Altman Z-Score?-15.39Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?2.77%Low
Short Interest?137.2K
Days to Cover?1.4
Free Float4.9M
Avg Daily Volume101.6K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.82Strong
Quick Ratio?2.82Strong
Cash Ratio?1.76Strong
Debt/Equity?5.09High
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
9
17.53HIGH
P/S?
Peers
100
S&P
75
1.67CHEAP
P/FCF?
N/A
EV/EBITDA?
S&P
97
-9.4CHEAP
EV/Sales?
Peers
100
S&P
77
1.88CHEAP
Returns & Efficiency
ROE?
S&P
3
-350.0%WEAK
ROA?
S&P
3
-33.8%WEAK
Cash Flow & Enterprise
FCF?$-25103000
Enterprise Value?$181.0M
Fundamentals ratios updated end of day